Understanding a Persistent Small Blind Spot in Your Vision

A macular hole is a small break in the fovea, the very center of the macula where vision is sharpest. Because the fovea handles the finest level of detail, even a small defect there creates a well-defined blind spot that directly affects reading, recognizing faces, and seeing anything directly in front of you.

Macular holes develop when the vitreous gel, the clear jelly-like substance that fills the inside of the eye, pulls on the foveal tissue. This pulling can create a defect that ranges from a partial-thickness dimpling to a full-thickness opening through the retinal layers. People with macular holes often notice that letters in the center of a word appear to be missing, or that there is a small gap in the middle of objects they are looking at directly. Macular holes occur more commonly in women and in people over the age of 60.

Central serous chorioretinopathy, or CSC, occurs when fluid leaks from the choroid (the vascular layer beneath the retina) and collects under the macula. This pooling of fluid lifts the light-sensitive cells away from their normal position, producing a scotoma that often appears as a dim or slightly dark spot in the central vision.

The blind spot from CSC is usually a relative scotoma, meaning vision in the affected area is reduced rather than completely absent. Patients often describe washed-out colors, mild distortion of straight lines, or a blurry central patch in one eye. CSC typically affects younger adults between 20 and 50 years old and is associated with emotional stress and the use of corticosteroid medications. Most acute cases resolve on their own within three to six months, but chronic or recurrent episodes can cause lasting photoreceptor damage if not properly managed.

An epiretinal membrane, or ERM, is a thin layer of fibrous tissue that forms on the surface of the macula. As this membrane slowly contracts, it wrinkles and distorts the retinal tissue beneath it, which can produce visual distortion and sometimes a small scotoma.

The symptoms from an epiretinal membrane tend to develop gradually, often over months or years. Patients may notice that straight lines appear wavy or bent, or that a small area of central vision seems slightly blurred or smeared. ERMs are most common in people over 50 and can develop after the vitreous gel separates from the retina (a posterior vitreous detachment), after retinal surgery, or as a result of inflammation inside the eye. Many ERMs are mild and only require periodic monitoring, while those causing significant visual symptoms may benefit from surgical removal.

Age-related macular degeneration, commonly called AMD, affects the macula as people age and can produce scotomas in both its dry and wet forms. In dry AMD, the light-sensitive photoreceptor cells in the macula gradually break down over time. When this progresses to its advanced stage, known as geographic atrophy, areas of cell loss create corresponding blind spots that may slowly enlarge.

In wet AMD, abnormal blood vessels grow beneath the macula and leak fluid or blood, which can distort and damage the retinal tissue above them. A scotoma from wet AMD can develop more rapidly than in dry AMD, sometimes appearing over days or weeks. Patients may notice a blurred, dark, or missing area in the center of their vision when looking directly at an object or printed text.

Paracentral acute middle maculopathy, known as PAMM, is a condition in which reduced blood flow in the deep capillary plexus (a network of tiny blood vessels within the retina) causes small, fixed scotomas near the center of vision. PAMM is identified on optical coherence tomography (OCT) imaging as a distinctive pattern of changes within a specific retinal layer called the inner nuclear layer.

Patients typically describe the sudden appearance of one or more small blind spots just off-center in one eye. PAMM can occur alongside other retinal vascular conditions, including retinal vein occlusion, and may be found in a meaningful proportion of those cases. It also occurs in people with diabetes or cardiovascular risk factors, and sometimes appears without a clearly identifiable cause. The scotomas from PAMM are typically permanent, which makes identifying any associated vascular condition particularly important.

Several additional conditions can produce a persistent small blind spot. Glaucoma, a disease of the optic nerve, can cause paracentral scotomas (blind spots just outside the very center of vision) that develop slowly and may go unnoticed for years. Optic neuritis, which is inflammation of the optic nerve, can produce a sudden fixed blind spot, often accompanied by pain when moving the eye. A branch retinal artery occlusion, a blockage of one of the small arteries supplying part of the retina, creates a scotoma in the region of retina that vessel serves. Solar retinopathy, damage to the fovea from looking at the sun or other intense light sources without eye protection, can leave a small permanent blind spot. Previous laser treatment near the macula may also create a small scotoma at the treatment site. Each of these has a distinct presentation that a retina specialist can identify through examination and imaging.

Full-thickness macular holes are treated with a surgical procedure called vitrectomy. During this surgery, the vitreous gel inside the eye is carefully removed. Any thin membrane present on the surface of the macula is gently peeled away to relieve traction on the foveal tissue. A small gas bubble is then placed inside the eye to press against the macula and support the closure of the hole from within.

After surgery, patients are typically asked to maintain a face-down position for a period of time to keep the gas bubble in contact with the macular surface while the hole heals. Closure rates for macular hole surgery are high, particularly when the hole is treated before it becomes large or long-standing. Many patients experience meaningful improvement in the central scotoma and overall visual acuity after successful repair, with the extent of recovery depending on the size and duration of the hole before surgery.

Acute CSC is typically managed with careful observation, since most cases resolve on their own within three to six months. If you are using corticosteroid medications, your retina specialist may work with your prescribing physician to consider whether adjusting that medication is appropriate and safe under proper medical supervision.

For chronic CSC that persists beyond several months, or for patients who experience recurrent episodes, photodynamic therapy using a medication called verteporfin can help reduce fluid recurrence and support resolution. Micropulse laser treatment is another option in chronic cases. As the fluid resolves, the scotoma typically fades, though some patients retain a mild residual blind spot if photoreceptor damage has already occurred.

When wet AMD is the identified cause of a scotoma, anti-VEGF (anti-vascular endothelial growth factor) injections are the established standard of care. These medications are delivered directly into the eye in a carefully controlled, in-office procedure. They work by blocking the abnormal blood vessel growth and fluid leakage that causes macular damage.

Several anti-VEGF medications are available, and the choice of agent and treatment schedule is determined by your retina specialist based on your specific anatomy, response to treatment, and individual circumstances. Early treatment provides the best opportunity to stabilize or reduce the scotoma and preserve central vision. Regular monitoring and ongoing treatment as needed help maintain the response over time.

For scotomas caused by conditions without a specific reversal treatment, such as healed PAMM, stable geographic atrophy, or resolved solar retinopathy, the focus shifts to regular monitoring and supporting the best possible use of remaining vision. Scheduled OCT and visual field testing allow your specialist to document stability or identify any changes that might call for a different approach.

Low-vision rehabilitation is a valuable resource for patients with a fixed scotoma. Eccentric viewing training teaches patients to shift their gaze to use a part of the retina adjacent to the scotoma for tasks that require detailed central vision, such as reading or facial recognition. Magnification devices, improved lighting, and electronic assistive technologies can also help reduce the day-to-day impact of a permanent blind spot and support continued independence.